Humasis, a multi-quantitative in vitro diagnostic company, will provide the Covid-19 antibody diagnostic kit to Myanmar.
Humasis said Wednesday that it would supply about 31,000 antibody diagnostic kits, “Humasis COVID-19 IgG / IgM Test,” by participating in the humanitarian aid project of the Ministry of Foreign Affairs for Myanmar.
|Humasis’ coronavirus test kits ready to be shipped to Myanmar|
Humasis’ Covid-19 IgG / IgM Test is an antibody diagnostics kit that detects antibodies formed to remove the virus that has entered the human body. The aid project is run by the foreign ministry and the Korea International Cooperation Agency.
Myanmar has reported about 180 confirmed persons since the first infected person appeared on March 23. However, the number of inspections per day is only 380 on average, as there is a small number of testing facilities in the Southeast Asian country.
“Humasis will do its best to help the world overcome the Covid-19 pandemic by actively taking part in humanitarian projects,” a Humasis official said,
The company has completed the product registration procedure with the U.S. Food and Drug Administration to win its emergency use approval. It has supplied more than three million test kits to about 30 nations, including Brazil, Germany, United Kingdom, France, and the U.S.
<© Korea Biomedical Review, All rights reserved.>